Rangeley Capital »

Kezar Life Sciences shares owned by Rangeley Capital

Quarter-by-quarter ownership of Kezar Life Sciences (KZR) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Kezar Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kezar Life Sciences held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kezar Life Sciences by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $541k 86k 6.29

More positions owned by Rangeley Capital

Warner Bros Discovery Com Ser A Call Option (WBD)
Golden Entmt (GDEN)
Calumet (CLMT)
Prothena Corp SHS (PRTA)
Yext (YEXT)
Arvinas Ord (ARVN)
Arbutus Biopharma (ABUS)
Avidity Biosciences Ord (RNA)
Repare Therapeutics Ord
Kennedy-Wilson Holdings (KW)
Seaport Entmt Group Common Stock (SEG)
Delek Us Holdings (DK)
Berto Acquisition Corp Ord Shs (TACO)
Grindr (GRND)
Plymouth Indl Reit

View all positions for Rangeley Capital

Top funds holding Kezar Life Sciences

BML Capital Management
Suvretta Capital Management
Tang Capital Management
Vanguard Group
Nantahala Capital Management
Affinity Asset Advisors
Stonepine Capital Management
Renaissance Technologies
Peapod Lane Capital
Acadian Asset Management
Susquehanna International
ADAR1 Capital Management
Ikarian Capital
BlackRock
Rangeley Capital

View all funds holding Kezar Life Sciences